<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d323">
    <sentence id="DDI-DrugBank.d323.s0" text="Co-administration of MYOBLOC and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated.">
        <entity id="DDI-DrugBank.d323.s0.e0" charOffset="21-27"
            type="brand" text="MYOBLOC"/>
        <entity id="DDI-DrugBank.d323.s0.e1" charOffset="33-47"
            type="group" text="aminoglycosides"/>
        <entity id="DDI-DrugBank.d323.s0.e2" charOffset="116-136"
            type="group" text="curare-like compounds"/>
        <entity id="DDI-DrugBank.d323.s0.e3" charOffset="198-202"
            type="drug" text="toxin"/>
        <pair id="DDI-DrugBank.d323.s0.p0" e1="DDI-DrugBank.d323.s0.e0"
            e2="DDI-DrugBank.d323.s0.e1" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d323.s0.p1" e1="DDI-DrugBank.d323.s0.e0"
            e2="DDI-DrugBank.d323.s0.e2" ddi="true" type="advise"/>
        <pair id="DDI-DrugBank.d323.s0.p2" e1="DDI-DrugBank.d323.s0.e0"
            e2="DDI-DrugBank.d323.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d323.s0.p3" e1="DDI-DrugBank.d323.s0.e1"
            e2="DDI-DrugBank.d323.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d323.s0.p4" e1="DDI-DrugBank.d323.s0.e1"
            e2="DDI-DrugBank.d323.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d323.s0.p5" e1="DDI-DrugBank.d323.s0.e2"
            e2="DDI-DrugBank.d323.s0.e3" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d323.s1" text="The effect of administering different botulinum neurotoxin serotypes at the same time or within less than 4 months of each other is unknown.">
        <entity id="DDI-DrugBank.d323.s1.e0" charOffset="38-57"
            type="group" text="botulinum neurotoxin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d323.s2" text="However, neuromuscular paralysis may be potentiated by co-administration or overlapping administration of different botulinum toxin serotypes.">
        <entity id="DDI-DrugBank.d323.s2.e0" charOffset="116-130"
            type="group" text="botulinum toxin"/>
    </sentence>
</document>
